Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma-Reference-Cited by-同舟云学术

Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma

Published:2019-09 Issue: Volume:138 Page:99-105
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Fleischmann Daniel Felix,Jenn Johanna,Corradini Stefanie^ORCID,Ruf Viktoria,Herms Jochen,Forbrig Robert,Unterrainer Marcus,Thon Niklas,Kreth Friedrich Wilhelm,Belka Claus,Niyazi Maximilian

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference31 articles.

1. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial;Roa;J Clin Oncol,2004

2. Short-course radiation plus temozolomide in elderly patients with glioblastoma;Perry;N Engl J Med,2017

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. 21 years of biologically effective dose;Fowler;Br J Radiol,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy;Radiotherapy and Oncology;2024-10

2. Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis;Frontiers in Immunology;2024-08-27

3. Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06);Clinical and Translational Radiation Oncology;2024-07

4. Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence;Journal of Personalized Medicine;2024-05-17

5. PRIDE: isotoxische Dosiseskalation beim Glioblastom;Forum;2024-04-02